HKEX's listing reforms: lower thresholds for weighted voting rights and an easier path for overseas issuers

Context

Hong Kong first allowed companies with weighted voting rights, often called dual-class shares, to list in 2018. The change brought in large technology groups that wanted founders to keep control after listing. The thresholds were set high, however, and in practice only very large companies qualified.

Since then, competition among listing venues has intensified, and Hong Kong's IPO market has recovered strongly in 2025 and 2026. HKEX published a consultation paper on 13 March 2026 with proposals to make its framework more competitive, and the consultation closed on 8 May.

What changed

On 24 July 2026, HKEX published its consultation conclusions. The proposals received strong, in many cases near-unanimous, support, and the new rules took effect on publication. The main changes are as follows.

WVR financial eligibility. A company can now list with WVR if its market capitalisation is at least HK$20 billion (previously HK$40 billion), or at least HK$6 billion with revenue of at least HK$600 million in the most recent audited year (previously HK$10 billion and HK$1 billion).

Voting power and economic interest. The cap on the weighted voting ratio rises from 10:1 to 20:1 for companies with a market capitalisation of at least HK$40 billion at listing. The minimum WVR shareholding can fall from 10% to 5%, provided that stake is worth at least HK$4 billion at listing.

The "innovative" test. The test has been refined to provide an explicit route to a WVR listing for non-tech issuers applying a new business model. Qualified biotech and specialist technology companies are presumed innovative even if they do not list under Chapter 18A or 18C, and the requirement for third-party validation by a sophisticated investor has been clarified.

Secondary listings. For overseas issuers without WVR, the market capitalisation threshold under the two-year track record test falls from HK$10 billion to HK$6 billion. WVR thresholds for secondary listings now match those for primary listings. HKEX will also publish streamlined guidance on converting a secondary listing to a primary listing.

Financial reporting. The allowance to use US GAAP extends to subsidiaries of US-listed parents and to companies with substantial US operations. US GAAP reporters no longer have to switch to HKFRS or IFRS on a US delisting.

Specialist routes. Commercialised biotech and specialist technology companies can choose the Chapter 18A or 18C route even if they meet the ordinary financial tests.

Filing and quality. Non-public (confidential) filing, previously limited to certain categories, is now open to all new applicants. If an application is returned for being substantially incomplete, HKEX will publish the identities and roles of the professional parties involved, not just the sponsor, together with the reasons.

HKEX described these changes as the first phase of its review, with a further consultation paper to come.

Why it matters

The changes lower the bar most significantly for mid-sized founder-led companies. A company worth HK$6 billion with HK$600 million in revenue is a meaningful business but far from a mega-cap. Under the old rules, its founders would have had to give up control or list elsewhere.

The secondary listing changes matter for companies already listed in the US, London or on a Recognised Stock Exchange. Bursa Malaysia joined the list of Recognised Stock Exchanges on 23 July, the day before the conclusions were published, which widens the pool of potential secondary listers in Southeast Asia.

Confidential filing reduces the reputational risk of a failed or delayed IPO, while publishing the professional parties behind returned applications is meant to keep standards high.

Implications for investors, families and businesses

For founders and family-controlled companies, WVR can now be an option at an earlier stage. It allows families to raise public capital while keeping control of strategy. The trade-off is that public investors will price in governance risk, and the safeguards that accompany WVR remain.

For investors, more WVR listings mean more companies where public shareholders have limited voting influence. It becomes more important to assess the founder's track record, independent board oversight and the sunset provisions attached to weighted votes.

For overseas-listed companies, particularly those with Asian operations or investors, a Hong Kong secondary listing is now more accessible.

For professional advisers, the enhanced Return Mechanism raises the stakes on application quality.

Questions to consider

• Would WVR help our family retain control through a listing, and are we comfortable with the governance obligations that come with it?
• Does our business model meet the refined "innovative" test?
• If we are listed overseas, do we now meet the secondary listing thresholds?
• How does confidential filing change our IPO timetable and communications?
• As investors, how do we assess governance in WVR companies?

Closing

Hong Kong's July reforms are pragmatic. They keep the safeguards built around WVR but lower the barriers that kept many founder-led companies away. With a second phase to come, the direction is clear: Hong Kong wants to be the natural listing venue for a broader range of Asian growth companies.